Amphastar Pharmaceuticals (AMPH) Cash from Investing Activities Growth (1y) (2014 - 2026)
Amphastar Pharmaceuticals (AMPH) Cash from Investing Activities Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 13.93% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 57.14% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -186.78% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 551.55% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 526.11% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -3,664.79% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -3.45% |
| 10 | Amphastar Pharmaceuticals | 867.92 Mn | 696.78 Mn | 70.32 Mn | -259.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -259.65% |
| Dec 31, 2025 | -69.77% |
| Sep 30, 2025 | 43.27% |
| Jun 30, 2025 | 99.11% |
| Mar 31, 2025 | -31.21% |
| Dec 31, 2024 | 65.38% |
| Sep 30, 2024 | -11.02% |
| Jun 30, 2024 | 86.26% |
| Mar 31, 2024 | 340.60% |
| Dec 31, 2023 | -44,899.56% |
| Sep 30, 2023 | -104.17% |
| Jun 30, 2023 | -6,117.38% |
| Mar 31, 2023 | 30.48% |
| Dec 31, 2022 | 98.08% |
| Sep 30, 2022 | -304.83% |
| Jun 30, 2022 | -92.29% |
| Mar 31, 2022 | -4.77% |
| Dec 31, 2021 | 1.82% |
| Sep 30, 2021 | 30.86% |
| Jun 30, 2021 | 57.74% |